BML Capital Management
ZIONSVILLE, INfiles as BML Capital Management, LLC
$175m in 15 US stocks at the end of 30 June 2026. The top 10 are 93.8% of the money. It changed about 15.6% of the portfolio this quarter.
Value
$175m
Stocks
15
Top 10 share
93.8%
Turnover
15.6%
What changed this quarter
New
Bought for the first time this quarter.
- enGene TherapeuticsENGN6.6% of the fund
Added
Bought more of a stock they already held.
- Kraft HeinzKHC6.3% of the fund+272%
- Outset MedicalOM6.2% of the fund+32%
- CarMaxKMX5.2% of the fund+11%
- Connect Biopharma HoldingsCNTB0.8% of the fund+40%
Cut
Sold some of their stake.
- Aclaris TherapeuticsACRS36.2% of the fund-16%
- Oramed PharmaceuticalsORMP2.4% of the fund-73%
Sold out
Sold their entire stake.
- Kezar Life Sciences-100%
Holdings
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Aclaris TherapeuticsACRS | 36.2% | $63m | 11,975,000 | -16% |
| Atea PharmaceuticalsAVIR | 18.5% | $32m | 6,952,330 | Held |
| enGene TherapeuticsENGN | 6.6% | $12m | 6,669,908 | New |
| Kraft HeinzKHC | 6.3% | $11m | 465,000 | +272% |
| Outset MedicalOM | 6.2% | $11m | 2,519,701 | +32% |
| CarMaxKMX | 5.2% | $9m | 172,500 | +11% |
| Tilly'sTLYS | 5.2% | $9m | 2,150,000 | Held |
| PMV PharmaceuticalsPMVP | 4.1% | $7m | 5,330,000 | Held |
| Instil BioTIL | 2.8% | $5m | 645,600 | Held |
| TargetTGT | 2.8% | $5m | 37,500 | Held |
| Oramed PharmaceuticalsORMP | 2.4% | $4m | 866,269 | -73% |
| Janux TherapeuticsJANX | 1.4% | $2m | 154,961 | Held |
| Pliant TherapeuticsPLRX | 1.0% | $2m | 1,546,137 | Held |
| Connect Biopharma HoldingsCNTB | 0.8% | $1m | 573,287 | +40% |
| ImageneBioIMA | 0.7% | $1m | 200,730 | Held |
Options (3)
- WalmartWMT
- Type
- Put
- Value
- $386,088
- Contracts
- 335
- Core ScientificCORZ
- Type
- Put
- Value
- $298,000
- Contracts
- 800
- TeslaTSLA
- Type
- Put
- Value
- $270,000
- Contracts
- 375
| Company | Type | Value | Contracts |
|---|---|---|---|
| WalmartWMT | Put | $386,088 | 335 |
| Core ScientificCORZ | Put | $298,000 | 800 |
| TeslaTSLA | Put | $270,000 | 375 |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 34.2% since 30 June 2025.
Where the money is
Health care80.6%
Retail & consumer10.4%
Everyday goods9.1%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.